Life Tech Provides SOLiD Systems to UK-Based Sequencing Hub for Translational Research Collaboration | GenomeWeb

By Julia Karow

Life Technologies said this week that through a collaboration with a sequencing center in Cambridge, UK, it is making its SOLiD platform available to scientists for translational research studies.

Under the collaboration, scientists at the Eastern Sequence and Informatics Hub at Addenbrooke's Hospital in Cambridge will use three SOLiD 3 Plus systems for targeted medical resequencing and whole-transcriptome studies in disease areas such as cancer, diabetes, and neurological disorders.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.